相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic relevance of oncological serum biomarkers in liver cancer patients undergoing transarterial chemoembolization therapy
Nikolaus Kohles et al.
TUMOR BIOLOGY (2012)
Evaluation of Absolute Serum alpha-Fetoprotein Levels in Liver Transplant for Hepatocellular Cancer
Brian Mailey et al.
ARCHIVES OF SURGERY (2011)
Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
Nikolaus Kohles et al.
BMC CANCER (2011)
Early identification of poor responders to transarterial chemoembolization for hepatocellular carcinoma
Ya-Ju Tsai et al.
HEPATOLOGY INTERNATIONAL (2011)
Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy
Teh I. Huo et al.
BMC GASTROENTEROLOGY (2010)
Early Alpha-Fetoprotein Response Predicts Treatment Efficacy of Antiangiogenic Systemic Therapy in Patients With Advanced Hepatocellular Carcinoma
Yu-Yun Shao et al.
CANCER (2010)
Hepatocellular carcinoma: a global view
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy
Kentaroh Yamamoto et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy
Stephen L. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival
Ahsun Riaz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Application of surveillance programs for hepatocellular carcinoma in the Asia-Pacific Region
Deepak Amarapurkar et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell
Xiaojun Yang et al.
CANCER LETTERS (2008)
Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
Evi N. Debruyne et al.
CLINICA CHIMICA ACTA (2008)
Clinical significance of α-fetoprotein:: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma
Noboru Mitsuhashi et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC
Hidenori Toyoda et al.
JOURNAL OF HEPATOLOGY (2008)
α-Fetoprotein shields hepatocellular carcinoma cells from apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand
Mengsen Li et al.
CANCER LETTERS (2007)
Staging hepatocellular carcinoma by a novel scoring system (BALAD score) based on serum markers
Hidenori Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:: Both or neither?
F Farinati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma
H Toyoda et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Management of hepatoceullular carcinoma
J Bruix et al.
HEPATOLOGY (2005)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma
S Fujiyama et al.
ONCOLOGY (2002)
分享论文
